ストックスクリーナーアプリを入手
1.01
6.52%
-0.06
Cardiol Therapeutics Inc (CRDL) 最新ニュース
Why Cardiol Therapeutics Inc Class A stock is gaining today - Wealth Awesome
Why Cardiol Therapeutics Inc Class A stock is tanking today - Wealth Awesome
CRDL Should I Buy - Intellectia AI
CRDL Stock Price, Quote & Chart - ChartMill
Enterprise value to revenue forward of Cardiol Therapeutics Inc. – BOATS:CRDL - TradingView
Why Cardiol Therapeutics Inc Class A stock is sliding today - Wealth Awesome
CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan
Price to earnings forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView
Enterprise value to revenue forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView
Cardiol Therapeutics Inc. Class A Actuals & Estimates (TSX:CRDL) - TradingView
Cardiol Therapeutics Inc. Class A Actuals & Estimates (NEO:CRDL) - TradingView
CRDL Forecast — Price Target — Prediction for 2027 - TradingView
Cardiol Therapeutics Inc. - Menafn
Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM - TipRanks
A2PA9E Forecast — Price Target — Prediction for 2027 - TradingView
Strong shareholder support at Cardiol Therapeutics (CRDL) 2026 AGM as all directors elected - Stock Titan
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - PR Newswire
Press Release: Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - Moomoo
Why Cardiol Therapeutics Inc Class A stock is rising today - Wealth Awesome
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance - TipRanks
Form 6K Cordel Group PLC For: 23 June By Investing.com - Investing.com India
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT - PR Newswire
Cardiol Therapeutics Inc (CRDL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardiol Therapeutics Inc (CRDL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardiol Therapeutics Inc (CRDL) Institutional Confidence - TradingKey
Cardiol Therapeutics Inc (CRDL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CRDL News | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL) - ChartMill
Cardiol Therapeutics Inc (CRDL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardiol Therapeutics Inc (CRDL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cardiol Therapeutics Inc (CRDL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna to Host Investor EventScience Day - Investing News Network
Cardiol Therapeutics Inc (CRDL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardiol Therapeutics Inc (CRDL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CRDL Q1 2026 Earnings: Narrower Loss Beats Estimates, Stock Rises 4.37%Post-Announcement Reaction - dars.gov.et
Cardiol Therapeutics (CRDL) Shows Modest Gains as Support Level Holds FirmBearish Sentiment - dars.gov.et
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Moderna to Present at Upcoming Conference in June 2026 - Investing News Network
CRDL Q1 2026 Earnings: Narrower-than-Expected Loss Signals Cost DisciplineConsensus Miss Rate - newsline.com
CRDLCardiol Therapeutics Inc Short Interest - Finviz
Cardiol Therapeutics (CRDL) Dips 4.7% as Shares Test Key Support LevelsWave Truncation - The Legal Advocate
Cardiol Therapeutics (CRDL) Sees Minor Decline, Holds Above Key SupportHull Moving Average - newsline.com
Cardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials - TipRanks
Cardiol Therapeutics (Nasdaq: CRDL) outlines 2026 virtual shareholder meeting - Stock Titan
Cardiol Therapeutics Inc. (CRDL) Modestly Advances as It Holds Above Key SupportStop Hunt - The Legal Advocate
Why Cardiol Therapeutics Stock Is Still in Focus While Nasdaq Is Closed - Bez Kabli
CRDL Q4 2025 Earnings: Narrower Loss Surpasses Estimates Amid Clinical ProgressSurprise Factor Analysis - newsline.com
CRDL Q4 2025 Earnings: Loss Narrows as EPS Beats Estimates by 14.2%Financial Data - newsline.com
CRDL Q4 2025 Earnings: Narrower Than Expected Loss as Cardiol Therapeutics Advances Clinical PipelineEPS Revision Trend - newsline.com
CRDL Stock Chart | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL) - ChartMill
Cardiol Therapeutics Inc (TSX:CRDL) Stock Price & 30 Year Financial Data - GuruFocus
CCORF Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $8 - Moomoo
(CRDL) On The My Stocks Page (CRDL:CA) - Stock Traders Daily
[SCHEDULE 13G/A] Cardiol Therapeutics Inc. Amended Passive Investment Disclosure - Stock Titan
Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation - Yahoo Finance
0.05%
2.12%
大文字化:
|
ボリューム (24 時間):